- Patent Title: Treatment of pulmonary and pleural fibrosis using HSP27 inhibitors
-
Application No.: US14573145Application Date: 2014-12-17
-
Publication No.: US09326993B2Publication Date: 2016-05-03
- Inventor: Philippe Bonniaud , Carmen Garrido , Guillaume Wettstein
- Applicant: ONCOGENEX TECHNOLOGIES INC.
- Applicant Address: CA Vancouver
- Assignee: ONCOGENEX TECHNOLOGIES INC.
- Current Assignee: ONCOGENEX TECHNOLOGIES INC.
- Current Assignee Address: CA Vancouver
- Agency: Larson & Anderson, LLC
- Main IPC: C12N15/11
- IPC: C12N15/11 ; C12N15/113 ; C12N15/115 ; A61K31/713 ; A61K31/74 ; A61K38/21 ; A61K39/395 ; A61K31/337 ; A61K31/353 ; A61K31/4375
Abstract:
Reduction of HSP27 expression is in beneficial in the treatment of pleural and pulmonary fibrosis and in particular subpleural fibrosis and IPF. Pharmaceutical compositions for this purpose contain an inhibitor of HSP27 and a pharmaceutically acceptable carrier.
Public/Granted literature
- US20150126584A1 Treatment of Pulmonary and Pleural Fibrosis Using HSP27 Inhibitors Public/Granted day:2015-05-07
Information query
IPC分类:
